According to scholarly articles, phage, a type of virus that infects bacteria, has demonstrated its effectiveness in treating different kinds of bacterial infections and diseases. However, clinical trials have failed in proving its value based on current regulatory requirements. Hence, scientists and researchers are working to discover what phage therapy has to offer, including preventing cholera infections. With an orally dosed bacteriophage cocktail targeting endemic strains of cholera, Minmin Yen, company co-founder and CEO of PhagePro, aims to provide immediate protection and disrupt cholera transmission among household members. Read full article here
